AM, F., H, A., JB, E., JM, O., & S, V. (2025). Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation. Pediatric cardiology, 46(7), 2137. https://doi.org/10.1007/s00246-024-03700-9
Chicago Style (17th ed.) CitationAM, Freddo, Ahmed H, Edelson JB, Ortega-Legaspi JM, and Vaikunth S. "Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation." Pediatric Cardiology 46, no. 7 (2025): 2137. https://doi.org/10.1007/s00246-024-03700-9.
MLA (9th ed.) CitationAM, Freddo, et al. "Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation." Pediatric Cardiology, vol. 46, no. 7, 2025, p. 2137, https://doi.org/10.1007/s00246-024-03700-9.
Warning: These citations may not always be 100% accurate.